All Stories

  1. Adenosine and Adenosine 5’-triphosphate Catabolism in Systemic Blood as a Potential Biomarker for Doxorubicin Cardiotoxicity in an Experimental Rat Model in vivo

    Article • Cardiovascular & Haematological Disorders - Drug Targets, October 2018, Bentham Science Publishers

    Dr Pollen K Yeung

  2. Effect of Cardiovascular Injury on Catabolism of Adenosine and Adenosine 5-‘Triphosphate in Systemic Blood in a Freely Moving Rat Model In Vivo

    Article • Drug Metabolism Letters, September 2016, Bentham Science Publishers

    Dr Pollen K Yeung

  3. A Pilot Study to Assess Adenosine 5’-triphosphate Metabolism in Red Blood Cells as a Drug Target for Potential Cardiovascular Protection

    Article • Cardiovascular & Haematological Disorders - Drug Targets, January 2016, Bentham Science Publishers

    Dr Pollen K Yeung

  4. Anti-Ischemia Drugs have no Effect on the In Vivo Metabolism of ATP by RBC in Normotensive Restrained Rats#

    Article • The Open Drug Metabolism Journal, June 2011, Bentham Science Publishers

    Dr Pollen K Yeung

  5. Pharmacokinetics and Hemodynamic Effects of Diltiazem in Rats Following Single vs Multiple Doses In Vivo#

    Article • The Open Drug Metabolism Journal, June 2009, Bentham Science Publishers

    Dr Pollen K Yeung